Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study - Wikidata - wikimedia - TriplyDB

Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study

Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study

http://www.wikidata.org/entity/Q28219210

about

Standards of medical care in diabetes--2012 Should adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease?Standards of medical care in diabetes--2013 Prevalence and predictors of ischemia and outcomes in outpatients with diabetes mellitus referred for single-photon emission computed tomography myocardial perfusion imaging.Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial Predictors of cardiovascular autonomic neuropathy in patients with type 1 diabetes.Standards of medical care in diabetes--2010.Cardiovascular risk assessment in patients with diabetes.Prognostic Value of Normal Perfusion but Impaired Left Ventricular Function in the Diabetic Heart on Quantitative Gated Myocardial Perfusion SPECT.Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen.Five-year outcomes in high-risk participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study: a post hoc analysis.Standards of medical care in diabetes--2011.Arterial stiffness and carotid intima-media thickness in diabetic peripheral neuropathy Prevalence and risk factors accounting for true silent myocardial ischemia: a pilot case-control study comparing type 2 diabetic with non-diabetic control subjects.The ECG vertigo in diabetes and cardiac autonomic neuropathy.Standards of medical care in diabetes--2009.The heart rate response to adenosine: a simple predictor of adverse cardiac outcomes in asymptomatic patients with type 2 diabetes Early detection of asymptomatic coronary artery disease in patients with type 2 diabetes mellitus The goal of blood pressure in the hypertensive patient with diabetes is defined: now the challenge is go from recommendations to practice.Screening asymptomatic patients with type 2 diabetes mellitus for coronary artery disease: does it improve patient outcome?Cardiovascular imaging in diabetes mellitus.The influence of insulin resistance, obesity, and diabetes mellitus on vascular tone and myocardial blood flow.Medical management and strategies to prevent coronary artery disease in patients with type 2 diabetes mellitus.Vascular imaging in diabetes.Cardiac risk assessment in asymptomatic diabetes: combining [corrected] different imaging modalities and surrogate markers?Relationship between silent myocardial ischemia and coronary artery disease risk factors.Prognosis of normal stress-only gated-SPECT myocardial perfusion imaging: a single center study.Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease.Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus.Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros.The impact of adenosine pharmacologic stress combined with low-level exercise in patients undergoing myocardial perfusion imaging (BIWAKO adenosine-Ex trial).Association between plasma homocysteine levels and end-organ damage in newly diagnosed type 2 diabetes mellitus patients.Microalbuminuria predicts silent myocardial ischaemia in type 2 diabetes patients.Lessons learned from the detection of ischemia in asymptomatic diabetics (DIAD) study.

P2860

Q24632533-171FF62F-24CF-455E-985C-87C939531F72 Q26851148-16D8C7AD-D135-4005-BEAF-AC255C0E01E2 Q29620309-D03C8CAD-83B9-4251-ACB3-A2BFDD46F8B0 Q30413284-6B6CFABC-510E-45D6-AE55-7B296E0F1FB0 Q30435687-7D7A5564-0C84-44B9-8349-A03A43683150 Q33165064-5DE0CF69-BF82-4CCD-A20C-7E2C01D9709C Q33554238-DCA022C2-5ABB-4CA8-8B94-0F7BAFD77023 Q33582582-2EA6510B-00D1-4FD2-BC02-C6EC68B24711 Q33669965-5A04C7B9-C11A-4A22-8D19-1F9B01D1FC24 Q34179368-B185A5C7-2138-4478-B5C1-22A7F82D4B26 Q34422149-92BEA4EC-AE9F-4327-B17C-BC93CA98CA10 Q34425055-106D63B2-002F-4B8F-B16F-C73725F838D3 Q34463555-0FCDAC3B-CB94-4F3B-8DFD-70993D32A429 Q34564322-EEC12ABC-FAF4-4184-8673-29FBB04D2571 Q35071142-47980C1C-0E07-4147-AB7B-5D0936143B21 Q37036416-3333FF39-9CB2-41AC-A9C6-6023FD757C4C Q37045913-025AFF53-F458-431A-A3D2-3B1457B9400E Q37320930-742283E2-B24F-4037-9C00-EF6DA9C9133F Q37681363-196D3788-0B47-4F9B-B394-740011CF7A2B Q37738235-A252B593-1844-406E-89BD-C694038556F3 Q37904795-1061C1E8-3062-40DC-9107-F559164BC3C8 Q37972078-5F441FBE-B4BB-4D44-AE7B-3B9539FB03DC Q38079914-38C1DBE6-AF60-48FC-B973-6C873AD8F702 Q38184961-60AF163E-8F7D-4BC3-BDE7-C302E50DDED8 Q42734797-904E0B4C-74AD-4006-B113-74A0DF62D403 Q43439740-38D5815F-FB4F-428A-BCD6-0DAD09D802A2 Q45913983-42DFF523-764D-4F2F-BFF5-4FC70CAFA4D6 Q46287219-5E3BC140-19D3-496B-8C41-3C5F142465C8 Q47135571-5FA3ECF3-F565-4989-A587-674799970CE9 Q48128845-2CCBF318-8E4D-4035-9F1B-0583EA743B91 Q50537740-43A96685-52BC-4D07-A9A9-67F38EB613E1 Q51285548-FC9630E9-4270-4DC2-88B0-E340DA9C4466 Q53124913-F600D1CA-5001-4232-A306-7F3EDDABF658 Q53338998-2829E2AA-3BBD-418F-BA8F-7125B848337C

P2860

Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study

http://www.wikidata.org/entity/Q28219210

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Resolution of asymptomatic myo ...... tomatic Diabetics (DIAD) study

@ast

Resolution of asymptomatic myo ...... tomatic Diabetics (DIAD) study

@en

Resolution of asymptomatic myo ...... tomatic Diabetics (DIAD) study

@nl

type

label

Resolution of asymptomatic myo ...... tomatic Diabetics (DIAD) study

@ast

Resolution of asymptomatic myo ...... tomatic Diabetics (DIAD) study

@en

Resolution of asymptomatic myo ...... tomatic Diabetics (DIAD) study

@nl

prefLabel

Resolution of asymptomatic myo ...... tomatic Diabetics (DIAD) study

@ast

Resolution of asymptomatic myo ...... tomatic Diabetics (DIAD) study

@en

Resolution of asymptomatic myo ...... tomatic Diabetics (DIAD) study

@nl

P1433

Q28219210-5EEA0731-4312-49B2-9ACD-A36FD69A1B18

P1476

Q28219210-2C0ADF33-F5F8-4520-B2F2-B97C79444A04

P2093

Q28219210-024C3428-9E07-41E4-A39B-5E80E5B31CBC

Q28219210-197F0749-FF1E-4DEF-A5C7-531450463530

Q28219210-1AA28F4D-8206-4F96-9B41-73AFE304B7F6

Q28219210-23772ADC-F418-4040-9B67-9CD58D4A1DF5

Q28219210-511CB980-D877-4378-BC5F-0AABDF54E2A9

Q28219210-8731A118-0627-4EC7-A264-D1618A2D04B1

Q28219210-ADE61AEC-D6FE-46C0-9022-D0A49A49D99F

Q28219210-B0192CD4-AA2D-43DB-B425-EBFFB8B48C7D

Q28219210-B0AF36EF-C26A-458E-B424-1377749B05A2

Q28219210-B955558F-DCA9-4840-B7A1-1547020AA22C

P304

Q28219210-6C13B433-A40A-4B2F-9E6A-94D310A8766D

P31

Q28219210-EA840AFA-CB73-483C-AFCF-65D279F0E310

P356

Q28219210-26707244-46D1-45AF-BF53-7E3785EFFB34

P407

Q28219210-B8FC39A7-0E5A-4A7B-934B-CEFAA146B533

P433

Q28219210-36135376-5F3C-4062-B613-A48FDBB7865D

P478

Q28219210-50921934-5A87-490C-8181-0D37F9B10A71

P577

Q28219210-27739E15-658F-449E-90A4-04721BE85079

P5875

Q28219210-5D75668C-98FE-4A7D-9929-7851411BDA28

P698

Q28219210-A5878CD0-FEE1-4C0D-AEE9-CF0D46EDE5CF

P921

Q28219210-0C5F27EA-23ED-476E-B6F2-3196CF5A305B

Q28219210-4126C089-C86A-47C1-A281-B947A6D28ACA

P356

P1433

P1476

Resolution of asymptomatic myo ...... tomatic Diabetics (DIAD) study

@en

P2093

Ami E Iskandrian

http://www.w3.org/2001/XMLSchema#string

Deborah A Chyun

http://www.w3.org/2001/XMLSchema#string

Eugene J Barrett

http://www.w3.org/2001/XMLSchema#string

Frans J Th Wackers

http://www.w3.org/2001/XMLSchema#string

Gary V Heller

http://www.w3.org/2001/XMLSchema#string

Janice A Davey

http://www.w3.org/2001/XMLSchema#string

Lawrence H Young

http://www.w3.org/2001/XMLSchema#string

Neil Filipchuk

http://www.w3.org/2001/XMLSchema#string

Raymond Taillefer

http://www.w3.org/2001/XMLSchema#string

Robert E Ratner

http://www.w3.org/2001/XMLSchema#string

P304

2892-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC07-1250

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6157636

http://www.w3.org/2001/XMLSchema#string

P698

17682123

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes